Ann: Botanix Partners with Telehealth Provider UpScriptHealth, page-7

I think news like this will help us continue to hold around this level, but I don't expect much in the way of SP climbing until we start getting a bit closer to the revised approval date. I expect we'll languish around 12-13c until the new year, perhaps even drop into the 11c range, but simply because the fundamentals aren't going to change much for BOT between now and closer to approval (i.e. no significant income). An uptick in royalty revenue will help the price, but again, I'm not expecting huge things. But this ongoing nonsense elsewhere of it dropping to 10c and lower, is clearly just fearmongering and has no actual basis other than a penis-measuring, head-up-your-own-arse, need for attention from some.